Young XLH Patients-Reported Experience with a Supportive Care Program

Young XLH Patients-Reported Experience with a Supportive Care Program

Anya Rothenbuhler,1 Iva Gueorguieva,2 Lydia Lichtenberger-Geslin,3 Christelle Audrain,1 Sylvie Soskin,4 Candace Bensignor,5 Sylvie Rossignol,4 Aurélia Bertholet-Thomas,6 Lorelei Naudeau,7 Justine Bacchetta,6 Agnès Linglart1,8 1AP-HP, INSERM, Endocrinology and Diabetes for Children, Physiologie et Ph...

Full description

Bibliographic Details
Main Authors:	Rothenbuhler A, Gueorguieva I, Lichtenberger-Geslin L, Audrain C, Soskin S, Bensignor C, Rossignol S, Bertholet-Thomas A, Naudeau L, Bacchetta J, Linglart A
Format:	Article
Language:	English
Published:	Dove Medical Press 2023-06-01
Series:	Patient Preference and Adherence
Subjects:	xlh patient support program axess support program nurses hypophosphatemia quality of life children
Online Access:	https://www.dovepress.com/young-xlh-patients-reported-experience-with-a-supportive-care-program-peer-reviewed-fulltext-article-PPA

Similar Items

The ankle in XLH: Reduced motion, power and quality of life
by: Celine Akta, et al.
Published: (2023-03-01)

PHEX<sup>L222P</sup> Mutation Increases <i>Phex</i> Expression in a New ENU Mouse Model for XLH Disease
by: Carole El Hakam, et al.
Published: (2022-07-01)

Growth pattern in children with X-linked hypophosphatemia treated with burosumab and growth hormone
by: Diana-Alexandra Ertl, et al.
Published: (2022-11-01)

Decreased Compressional Sound Velocity Is an Indicator for Compromised Bone Stiffness in X-Linked Hypophosphatemic Rickets (XLH)
by: Adalbert Raimann, et al.
Published: (2020-06-01)

Persistent Lower Limb Deformities Despite Amelioration of Rickets in X-Linked Hypophosphatemia (XLH) - A Prospective Observational Study
by: Gabriel T. Mindler, et al.
Published: (2022-03-01)

Metabolomics of Plasma in XLH Patients with Arterial Hypertension: New Insights into the Underlying Mechanisms
by: Luis Carlos López-Romero, et al.
Published: (2024-03-01)

The International X-Linked Hypophosphatemia (XLH) Registry: first interim analysis of baseline demographic, genetic and clinical data
by: Gema Ariceta, et al.
Published: (2023-09-01)

Positive Response to One-Year Treatment With Burosumab in Pediatric Patients With X-Linked Hypophosphatemia
by: Silvia Martín Ramos, et al.
Published: (2020-02-01)

Clinical guidelines for burosumab in the treatment of XLH in children and adolescents: British paediatric and adolescent bone group recommendations
by: Raja Padidela, et al.
Published: (2020-10-01)

Kbus/Idr, a mutant mouse strain with skeletal abnormalities and hypophosphatemia: Identification as an allele of 'Hyp'
by: Kimura Atsushi, et al.
Published: (2011-08-01)

Phenotypic characterization of X-linked hypophosphatemia in pediatric Spanish population
by: Enrique Rodríguez-Rubio, et al.
Published: (2021-02-01)

Cellular and Molecular Alterations Underlying Abnormal Bone Growth in X-Linked Hypophosphatemia
by: Rocío Fuente, et al.
Published: (2022-01-01)

Anticipated effects of burosumab treatment on long-term clinical sequelae in XLH: expert perspectives
by: Lothar Seefried, et al.
Published: (2023-07-01)

Clinical Evidence for the Benefits of Burosumab Therapy for X-Linked Hypophosphatemia (XLH) and Other Conditions in Adults and Children
by: Aaron Schindeler, et al.
Published: (2020-05-01)

Oral health and oral-health-related quality of life in people with X-linked hypophosphatemia
by: Jannik Steur, et al.
Published: (2024-02-01)

The international X-linked hypophosphataemia (XLH) registry (NCT03193476): rationale for and description of an international, observational study
by: Raja Padidela, et al.
Published: (2020-06-01)

Oral symptoms and oral health-related quality of life of individuals with x-linked hypophosphatemia
by: Marcel Hanisch, et al.
Published: (2019-03-01)

FGF23 and its role in X-linked hypophosphatemia-related morbidity
by: Signe Sparre Beck-Nielsen, et al.
Published: (2019-02-01)

Development of Enthesopathies and Joint Structural Damage in a Murine Model of X-Linked Hypophosphatemia
by: Carole-Anne Faraji-Bellée, et al.
Published: (2020-09-01)

Increased prevalence of overweight and obesity in children with X-linked hypophosphatemia
by: Volha V Zhukouskaya, et al.
Published: (2020-02-01)

Burosumab - new potent treatment for X-linked hypophosphatemia and tumor-induced osteomalacia
by: Magda Wojtuś, et al.
Published: (2023-07-01)

Real‐world data of Brazilian adults with X‐linked hypophosphatemia (XLH) treated with burosumab and comparison with other worldwide cohorts
by: Maria Helena Vaisbich, et al.
Published: (2024-02-01)

Burosumab for X-linked hypophosphatemia in children and adolescents: Opinion based on early experience in seven European countries
by: M. Zulf Mughal, et al.
Published: (2023-01-01)

Dental health of pediatric patients with X-linked hypophosphatemia (XLH) after three years of burosumab therapy
by: Rafi Brener, et al.
Published: (2022-08-01)

Dental health of patients with X-linked hypophosphatemia: A controlled study
by: Amila Larsson, et al.
Published: (2023-03-01)

XLH Matters 2022: Insights and recommendations to improve outcomes for people living with X-linked hypophosphataemia (XLH)
by: Lothar Seefried, et al.
Published: (2023-10-01)

The effect of a supportive program on coping strategies and stress in women diagnosed with breast cancer: A randomized controlled clinical trial
by: Elahe Samami, et al.
Published: (2021-05-01)

Complications and Treatments in Adult X-Linked Hypophosphatemia
by: Yasuo Imanishi, et al.
Published: (2022-09-01)

X-linked hypophosphatemic rickets: from diagnosis to management
by: Eujin Park, et al.
Published: (2024-01-01)

Improvement of cognition for smoking cessation support in nurses who received Japanese Smoking Cessation Educational Program: Program contents and evaluation methods, background of participants
by: Izumi Sezai, et al.
Published: (2019-10-01)

Combined treatment by burosumab and a calcimimetic can ameliorate hypophosphatemia due to excessive actions of FGF23 and PTH in adult XLH with tertiary hyperparathyroidism: A case report
by: Yuichi Takashi, et al.
Published: (2022-12-01)

Insights into the Molecular and Hormonal Regulation of Complications of X-Linked Hypophosphatemia
by: Supriya Jagga, et al.
Published: (2023-03-01)

Grief Support Programs Implemented to Reduce the Effects of Grief on Family
by: Buket Şimşek Arslan, et al.
Published: (2019-09-01)

Implementation support practitioners – a proposal for consolidating a diverse evidence base
by: Bianca Albers, et al.
Published: (2020-05-01)

Patient-Support Program in Diabetes Care During the Covid-19 Pandemic: An Italian Multicentric Experience
by: Natalicchio A, et al.
Published: (2022-01-01)

Diagnosis and Treatment of Hypophosphatemia in Young Turkeys
by: Cumali Özkan*, Abdullah Kaya, Loğman Aslan1 and Yakup Akgül
Published: (2012-01-01)

Adherence rates and health care costs in Crohn's disease patients receiving certolizumab pegol with and without home health nurse assistance: results from a retrospective analysis of patient claims and home health nurse data
by: Wolf DC, et al.
Published: (2018-05-01)

Gitelman syndrome with hypocalcemia: one case report
by: Fei-jian Liu, et al.
Published: (2024-03-01)

Phosphate
by: Kundan Mittal
Published: (2019-01-01)

Fibroblast growth factor-23 and hypophosphatemia in chronic obstructive pulmonary disease patients
by: Elsammak Mohamed Y., et al.
Published: (2012-01-01)